MSI-1, a stem cell marker known to be dysregulated in endometriosis and endometrial cancer [20], was expressed in around two-thirds of the tissue samples in the AM group, in contrast to only about one-third in the non-AM group. Here, MSI1 is linked to endometrial cancer.